INBX

Inhibrx Biosciences, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$63.53

Market Cap

$927.98M

Beta

1.51

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+550.00%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y-15.80%

P/E Ratio0.0

PEG Ratio—

FCF Yield-13.99%

Debt / Equity13.39

Interest Coverage-11.1x

No credit card required

Already have an account? Sign in to view the full analysis for INBX.